Please enable Javascript
Conferences
Partners
Expert Interviews
Subscribe
Breast Cancers Today
HER2 Breast Cancer
HR Breast Cancer
Triple-Negative Breast Cancer
Genetics & Breast Cancer
Gastro Today
Inflammatory Bowel Disease
Irritable Bowel Syndrome
Hepatitis
Heme Today
Anemia
Deep Vein Thrombosis
Essential Thrombocythemia
Hemophilia
Immune Thrombocytopenic Purpura
Myelodysplastic Syndromes
Myelofibrosis
Myeloproliferative Neoplasms
PNH
Polycythemia Vera
Pulmonary Embolism
Sickle Cell Disease
Thrombocytopenia
Thrombophilia
Thrombosis
Thrombotic Thrombocytopenic Purpura
Venous Thromboembolism
von Willebrand Disease
Metabolic Care Today
Diabetes
Obesity
Nephrology Times
Acute Kidney Injury
ADPKD
Anemia and Kidney Disease
Chronic Kidney Disease
COVID-19 and Kidney Disease
Diabetes and Hypertension
End-Stage Renal Disease
Gout
Hyperkalemia
IgAN
Kidney Transplantation
Metabolic Acidosis
Sleep
More
Career News
Future of Medicine
Health and Wellness
— HIV
Infectious Diseases
Lupus
Neurology
Oncology
Ophthalmology
— Demodex Blepharitis
Orthopedics
Pharmacology
Pulmonology
Rheumatology
Urology
Ken Culver, MD
Articles by Ken Culver, MD
ALK Positive Announces Formation of Scientific Advisory Board
Ken Culver, MD
ALK+ NSCLC
|
July 10, 2025
The 12-member board will guide the guide the patient-driven organization’s research and strategic priorities.
View More
The ALK Life Study: Dr. Culver Shares Study Insights, Goals at WCLC 2024
Ken Culver, MD
WCLC 2024
|
September 17, 2024
Ken Culver, MD, Director of Research and Clinical Affairs at ALK Positive, discusses the on-going ALK Life Study.
View More